Population pharmacokinetics of recombinant factor VIII: the relationships of pharmacokinetics to age and body weight

S Björkman, MS Oh, G Spotts, P Schroth… - Blood, The Journal …, 2012 - ashpublications.org
Comparison of the pharmacokinetics (PK) of a coagulation factor between groups of patients
can be biased by differences in study protocols, in particular between blood sampling …

Serum circulating human mRNA profiling and its utility for oral cancer detection

Y Li, D Elashoff, M Oh, U Sinha… - Journal of Clinical …, 2006 - ascopubs.org
Purpose The purpose of this study is to explore the presence of informative RNA biomarkers
from human serum transcriptome, and evaluate the serum transcriptome diagnostics for …

Global expression-based classification of lymph node metastasis and extracapsular spread of oral tongue squamous cell carcinoma

X Zhou, S Temam, M Oh, N Pungpravat, BL Huang… - Neoplasia, 2006 - Elsevier
Regional lymph node metastasis is a critical event in oral tongue squamous cell carcinoma (OTSCC)
progression. The identification of biomarkers associated with the metastatic …

A controlled trial of intravenous immunoglobulin in multifocal motor neuropathy

…, IVIg in MMN Study Team, MS Oh… - Journal of the …, 2013 - Wiley Online Library
Intravenous immunoglobulin ( IVIG ) has become the standard treatment for multifocal motor
neuropathy ( MMN ) based on limited data. To critically assess the efficacy, safety, and …

Evaluation of the preliminary definitions of minimal disease activity and remission in an early seropositive rheumatoid arthritis cohort

D Khanna, M Oh, DE Furst, V Ranganath… - Arthritis Care & …, 2007 - Wiley Online Library
Objective To evaluate published proposed definitions of minimal disease activity (MDA) and
remission in patients with early rheumatoid arthritis (RA). Methods The cohort comprised …

A female preponderance for chemically induced lupus in SJL/J mice

DL Smith, X Dong, S Du, MS Oh, RR Singh… - Clinical …, 2007 - Elsevier
Both spontaneous and chemically induced rodent models of autoimmune nephritis and
autoantibody production have been explored to understand mechanisms involved in human …

[HTML][HTML] Comparative clinical efficacy and safety of the proposed biosimilar ABP 710 with infliximab reference product in patients with rheumatoid arthritis

MC Genovese, J Sanchez-Burson, MS Oh… - Arthritis Research & …, 2020 - Springer
Background ABP 710 is being developed as a biosimilar to infliximab reference product (RP).
Analytical similarity and pharmacokinetic equivalence between the two have been …

Correlation of single time-point damage scores with observed progression of radiographic damage during the first 6 years of rheumatoid arthritis.

HE Paulus, M Oh, JT Sharp, RH Gold… - The Journal of …, 2003 - jrheum.org
OBJECTIVE: Aggressive treatment of early rheumatoid arthritis (RA) is recommended to
prevent irreversible joint damage. We evaluated the usefulness of single time-point joint …

Pharmacokinetic similarity of ABP 710, a proposed biosimilar to infliximab: results from a randomized, single‐blind, single‐dose, parallel‐group study in healthy …

V Chow, MS Oh, MA Gessner… - … Pharmacology in Drug …, 2020 - Wiley Online Library
This was a randomized, single‐blind, single‐dose, 3‐arm parallel‐group study. Healthy
subjects were randomized to receive ABP 710 (n = 50) or infliximab reference product (RP) …

Classifying structural joint damage in rheumatoid arthritis as progressive or nonprogressive using a composite definition of joint radiographic change: a preliminary …

HE Paulus, MS Oh, JT Sharp, RH Gold… - … : Official Journal of …, 2004 - Wiley Online Library
Objective To categorize radiographic joint damage as progressive or nonprogressive in
individuals with rheumatoid arthritis (RA) participating in clinical studies. Methods Using the total …